kabutan

Mochida Pharma, First Half Ordinary Profit Increases by 27%, Jul-Sep Ordinary Profit Increases by 40%

Tue Nov 4, 2025 2:00 pm JST Earnings

4534 Mochida Pharmaceutical Co.,Ltd. 【J-GAAP】

Earnings Report

Mochida Pharmaceutical Co.,Ltd. <4534> [TSE Prime] announced its financial results in the afternoon session on November 4th (14:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) increased 27.0% from the same period last year, reaching 5.17 billion yen. Progress toward the full-year plan of 7.50 billion yen was 69.1%, also surpassing the five-year average of 56.2%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to drop 41.8% from the same period last year to 2.32 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit increased 40.0% from the same period last year, reaching 2.39 billion yen. The operating profit margin improved from 6.2% in the same period last year to 8.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 49,476 3,952 4,053 2,838 78.4 67.1 Nov 2, 2023 J-GAAP
Apr - Sep, 2024 51,096 3,793 4,079 2,825 79.7 50.6 Nov 1, 2024 J-GAAP
Apr - Sep, 2025 54,985 4,967 5,179 3,856 108.8 69.1 Nov 4, 2025 J-GAAP
YoY +7.6% +31.0% +27.0% +36.5% +36.5%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance ー ー ー ー － 40 May 12, 2025 J-GAAP
Apr - Sep, 2025 Results 54,985 4,967 5,179 3,856 108.8 40 Nov 4, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 54,063 4,333 3,988 2,860 80.7 40 May 12, 2025 J-GAAP
Oct - Mar, 2025 Guidance 55,515 2,033 2,321 1,544 43.6 40 Nov 4, 2025 J-GAAP
YoY +2.7% -53.1% -41.8% -46.0% -46.0%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 102,885 5,802 6,037 4,547 126.8 80 May 13, 2024 J-GAAP
Mar, 2025 105,159 8,126 8,067 5,685 160.4 80 May 12, 2025 J-GAAP
Mar, 2026 Guidance 110,500 7,000 7,500 5,400 152.3 80 May 12, 2025 J-GAAP
YoY +5.1% -13.9% -7.0% -5.0% -5.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 25,689 1,604 1,712 1,271 35.9 6.2 Nov 1, 2024 J-GAAP
Oct - Dec, 2024 29,635 3,450 3,561 2,780 78.4 11.6 Feb 7, 2025 J-GAAP
Jan - Mar, 2025 24,428 883 427 80 2.3 3.6 May 12, 2025 J-GAAP
Apr - Jun, 2025 26,631 2,572 2,783 1,894 53.4 9.7 Aug 1, 2025 J-GAAP
Jul - Sep, 2025 28,354 2,395 2,396 1,962 55.4 8.4 Nov 4, 2025 J-GAAP
YoY +10.4% +49.3% +40.0% +54.4% +54.4%

Related Articles